Focal arm weakness following intradetrusor botulinum toxin administration in spinal cord injury: Report of two cases
| Autor: | Peter H. Gorman, Andrew Shapiro, Henry S. York, Christopher Goodrich |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Weakness
030232 urology & nephrology Botulinum toxin injection Context (language use) Case Reports Chemodenervation 03 medical and health sciences 0302 clinical medicine medicine Humans Botulinum Toxins Type A Urinary Bladder Neurogenic Tetraplegia Spinal cord injury Spinal Cord Injuries Urinary Bladder Overactive business.industry medicine.disease Botulinum toxin Urodynamics Neuromuscular Agents Anesthesia Arm Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | J Spinal Cord Med |
| ISSN: | 2045-7723 1079-0268 |
| DOI: | 10.1080/10790268.2018.1464693 |
| Popis: | Context: Outpatient Spinal Cord Injury follow-up practice Findings: We present two cases of individuals with tetraplegia who experienced proximal arm weakness temporally related to the administration of intradetrusor onabotulinumtoxinA without other systemic effects. This arm weakness lasted approximately three months in both cases, whereas the effect of the toxin on the bladder lasted for over six months. In one of the cases, the pattern of proximal arm weakness after intravesicular botulinum toxin injection recurred after repeat injection. Conclusion: These cases represent a previously unreported phenomenon of proximal focal weakness associated with the use of intradetrusor chemodenervation. Possible mechanisms for these cases are discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|